Latest News for: nektar

Edit

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke ...

Business Wire 21 Mar 2026
... who purchased or otherwise acquired Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ.
Edit

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

PR Newswire 21 Mar 2026
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ ... To join the Nektar class action, go to https.//rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.
Edit

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 ...

Billings Gazette 21 Mar 2026
SAN FRANCISCO, March 20, 2026 /PRNewswire/ -- Nektar ...
Edit

ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before

Enid News & Eagle 20 Mar 2026
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- ... .
Edit

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire 20 Mar 2026
LOS ANGELES, March 20, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nektar Therapeutics ("Nektar" or "the Company") (NASDAQ.
Edit

NKTR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nektar

The Eagle-Tribune 20 Mar 2026
NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nektar Therapeutics (NASDAQ. NKTR) ... .
Edit

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR

PR Newswire 20 Mar 2026
LOS ANGELES, March 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nektar Therapeutics ("Nektar" or "the Company") (NASDAQ ... Nektar failed to follow ...
Edit

NEKTAR THERAPEUTICS (NKTR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Nektar Therapeutics Investors of Upcoming Deadline

Nasdaq Globe Newswire 19 Mar 2026
Nektar Shareholders Between February 26, 2025 and December 15, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit ... .
Edit

ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline ...

Nasdaq Globe Newswire 19 Mar 2026
... reminds purchasers of securities of Nektar Therapeutics (NASDAQ.
Edit

Deadline Approaching: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Law Offices of ...

Business Wire 19 Mar 2026
... filed on behalf of investors who purchased Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ.
Edit

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing Clinical Enrollment Standards: SueWallSt

PR Newswire 19 Mar 2026
NEW YORK, March 19, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Nektar Therapeutics (NASDAQ ... Nektar shares fell $4.14 ... Join the Nektar recovery action or contact Joseph E.
Edit

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

PR Newswire 19 Mar 2026
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ ... Nektar is a ...
Edit

NKTR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities ...

Nasdaq Globe Newswire 18 Mar 2026
Faruqi & Faruqi, LLP Securities Litigation Partner�James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options ... .
Edit

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to ...

Business Wire 18 Mar 2026
NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP reminds purchasers of Nektar Therapeutics (NASDAQ.
Edit

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Nektar Therapeutics ...

Business Wire 18 Mar 2026
... who purchased or otherwise acquired Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ.

Article Search

tools
×
×
×
×